Preparation and thermodynamic properties of Felodipine form IV

[1]  R. Ambrus,et al.  Polymorph screening of an active material. , 2013, Journal of pharmaceutical and biomedical analysis.

[2]  Ping Yang,et al.  Physicochemical characterization of felodipine-kollidon VA64 amorphous solid dispersions prepared by hot-melt extrusion. , 2013, Journal of pharmaceutical sciences.

[3]  Y. Yoshihashi,et al.  Polymorphic and pseudomorphic transformation behavior of acyclovir based on thermodynamics and crystallography , 2013, Journal of Thermal Analysis and Calorimetry.

[4]  R. Chadha,et al.  Thermoanalytical and spectroscopic studies on different crystal forms of nevirapine , 2013, Journal of Thermal Analysis and Calorimetry.

[5]  V. Tkachev,et al.  Polymorphs and solvates of felodipine: analysis of crystal structures and thermodynamic aspects of sublimation and solubility processes , 2012 .

[6]  A. Bond,et al.  Crystallization and Polymorphism of Felodipine , 2012 .

[7]  J. Elguero.  Polymorphism and Desmotropy in Heterocyclic Crystal Structures , 2011 .

[8]  S. Rohani,et al.  Polymorphism and crystallization of active pharmaceutical ingredients (APIs). , 2009, Current medicinal chemistry.

[9]  S. Velaga,et al.  Polymorph control of felodipine form II in an attempted cocrystallization , 2009 .

[10]  Jukka Rantanen,et al.  Solid form screening--a review. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[11]  G. Desiraju.  Polymorphism : The Same and Not Quite the Same , 2008 .

[12]  W. Cabri,et al.  Polymorphisms and Patent, Market, and Legal Battles: Cefdinir Case Study , 2007 .

[13]  Lynne S Taylor,et al.  Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. , 2006, Journal of pharmaceutical sciences.

[14]  James S. Chickos,et al.  Enthalpies of Vaporization of Organic and Organometallic Compounds, 1880-2002 , 2003 .

[15]  A. Poso,et al.  Comparison of Experimental Methods and Theoretical Calculations on Crystal Energies of ‘Isoenergetic’ Polymorphs of Cimetidine , 1999 .

[16]  N. Nussinovitch,et al.  Felodipine in the treatment of severe refractory hypertension. , 1996, Journal of human hypertension.

[17]  S. Srčič,et al.  Investigation of felodipine polymorphism and its glassy state , 1992 .

[18]  R. Fossheim.  Crystal structure of the dihydropyridine Ca2+ antagonist felodipine. Dihydropyridine binding prerequisites assessed from crystallographic data. , 1986, Journal of medicinal chemistry.

[19]  A. Burger,et al.  On the polymorphism of pharmaceuticals and other molecular crystals. I , 1979 .

[20]  A. Burger,et al.  On the polymorphism of pharmaceuticals and other molecular crystals. II , 1979 .

[21]  W. Mccrone,et al.  Pharmaceutical applications of polymorphism. , 1969, Journal of pharmaceutical sciences.